can you eat too little on semaglutide How Long Does It Take for to Work? What to Eat and What

Aching joints

No other single-agent weight loss peptide has posted numbers like that in a randomized controlled trial

Tirzepatide in 2026 While semaglutide targets the GLP-1 receptor exclusively, tirzepatide activates both GLP-1 and GIP receptorsa dual-agonist mechanism showing slightly higher average weight loss (21-23%) in head-to-head comparisons

A NewYork-Presbyterian study confirmed that women in menopause benefit from GLP-1 weight loss medications as much as younger women, dispelling the common concern that these medications might be less effective after menopause

GLP-1 cardiovascular outcomes Multiple large-scale cardiovascular outcomes trials have demonstrated that GLP-1 agonists reduce the risk of major adverse cardiovascular events, including heart attack, stroke, and cardiovascular death

Week two of semaglutide is when most people quit